CD44 and neoplasm: Tumor progression is marked by the heightened invasiveness of tumors, which is closely associated with their increased metastatic potential.[22] Here, we aim to evaluate the expression of EMT biomarkers (CD44, CD133 and CD166) in the tumor cells after colonization by tumor‐associated bacteria.